These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28285984)

  • 1. The ADVANCE Code of Conduct for collaborative vaccine studies.
    Kurz X; Bauchau V; Mahy P; Glismann S; van der Aa LM; Simondon F;
    Vaccine; 2017 Apr; 35(15):1844-1855. PubMed ID: 28285984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe.
    Torcel-Pagnon L; Bauchau V; Mahy P; Tin Tin Htar M; van der Sande M; Mahé C; Krause TG; Charrat A; Simondon F; Kurz X;
    Vaccine; 2019 May; 37(25):3278-3289. PubMed ID: 31072735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines.
    Sturkenboom M; Bahri P; Chiucchiuini A; Grove Krause T; Hahné S; Khromava A; Kokki M; Kramarz P; Kurz X; Larson HJ; de Lusignan S; Mahy P; Torcel-Pagnon L; Titievsky L; Bauchau V;
    Vaccine; 2020 Dec; 38 Suppl 2():B1-B7. PubMed ID: 31677952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.
    Abelin A; Colegate T; Gardner S; Hehme N; Palache A
    Vaccine; 2011 Feb; 29(6):1135-8. PubMed ID: 21115061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.
    Dodd CN; Romio SA; Black S; Vellozzi C; Andrews N; Sturkenboom M; Zuber P; Hua W; Bonhoeffer J; Buttery J; Crawford N; Deceuninck G; de Vries C; De Wals P; Gutierrez-Gimeno MV; Heijbel H; Hughes H; Hur K; Hviid A; Kelman J; Kilpi T; Chuang SK; Macartney K; Rett M; Lopez-Callada VR; Salmon D; Gimenez-Sanchez F; Sanz N; Silverman B; Storsaeter J; Thirugnanam U; van der Maas N; Yih K; Zhang T; Izurieta H;
    Vaccine; 2013 Sep; 31(40):4448-58. PubMed ID: 23770307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing collaborative vaccine benefits and safety research in Europe via the ADVANCE code of conduct.
    Sturkenboom M
    Vaccine; 2018 Jan; 36(2):194-195. PubMed ID: 29153582
    [No Abstract]   [Full Text] [Related]  

  • 7. The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE - a European initiative.
    Díez-Domingo J; Torcel-Pagnon L; Carmona A; Launay O; Dos Santos G; Rizzo C; Haag M; Stuurman A; Nauta J; Vannacci A; de Lusignan S; Del Rey E; Levi M; Lina B; Bellino S; Nye S; Neels P; Nohynek H; Mahé C;
    Expert Rev Vaccines; 2022 Dec; 21(12):1701-1710. PubMed ID: 36261918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pandemic 2009-2010 influenza vaccine: six lessons learned and the way forward (Allegro not Adagio).
    Poland GA
    Vaccine; 2011 Jan; 29(4):613-4. PubMed ID: 21193121
    [No Abstract]   [Full Text] [Related]  

  • 10. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the implementation of the H1N1 pandemic influenza vaccine in local health departments (LHDs) in North Carolina.
    DiBiase LM; Davis SE; Rosselli R; Horney J
    Vaccine; 2011 May; 29(23):3969-76. PubMed ID: 21477677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccination and intention to receive the pandemic H1N1 influenza vaccine among healthcare workers of British Columbia, Canada: a cross-sectional study.
    Kaboli F; Astrakianakis G; Li G; Guzman J; Donovan T; Naus M
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1017-24. PubMed ID: 20707670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance.
    Kurz X; Domergue F; Slattery J; Segec A; Szmigiel A; Hidalgo-Simon A
    Vaccine; 2011 Jun; 29(26):4378-87. PubMed ID: 21501644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.
    Emborg HD; Krause TG; Hviid A; Simonsen J; Mølbak K
    BMJ; 2011 Jan; 344():d7901. PubMed ID: 22277542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience and lessons from surveillance and studies of the 2009 pandemic in Europe.
    Nicoll A; Ammon A; Amato Gauci A; Ciancio B; Zucs P; Devaux I; Plata F; Mazick A; Mølbak K; Asikainen T; Kramarz P
    Public Health; 2010 Jan; 124(1):14-23. PubMed ID: 20141821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seasonal and pandemic influenza vaccine: recommendations to families of at-risk children during the 2009-10 season.
    Romano M; Pandolfi E; Marino MG; Gesualdo F; Rizzo C; Carloni E; Macchiaiolo M; Tozzi AE
    Eur J Public Health; 2012 Dec; 22(6):821-4. PubMed ID: 22315460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.
    Seale H; Kaur R; Wang Q; Yang P; Zhang Y; Wang X; Li X; Zhang H; Zhang Z; MacIntyre CR
    Vaccine; 2011 Feb; 29(8):1605-10. PubMed ID: 21211593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why were Turks unwilling to accept the A/H1N1 influenza-pandemic vaccination? People's beliefs and perceptions about the swine flu outbreak and vaccine in the later stage of the epidemic.
    Gaygısız Ü; Gaygısız E; Özkan T; Lajunen T
    Vaccine; 2010 Dec; 29(2):329-33. PubMed ID: 20979988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of pandemic H1N1 vaccines in children and adolescents.
    Wijnans L; de Bie S; Dieleman J; Bonhoeffer J; Sturkenboom M
    Vaccine; 2011 Oct; 29(43):7559-71. PubMed ID: 21821086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pandemic influenza A(H1N1) 2009 vaccines in the European Union.
    Johansen K; Nicoll A; Ciancio BC; Kramarz P
    Euro Surveill; 2009 Oct; 14(41):19361. PubMed ID: 19883538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.